
MNKD Competitors
MannKind Corporation
$3.85
-$0.10(-2.53%)
48
Overall
20
Value
91
Tech
34
Quality
Market Cap
$1.24B
Volume
4.18M
52W Range
$2.23 - $6.51
Target Price
$8.33
MNKD competitors: HALO, NVO, MRK, LLY, NKTR. MannKind Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
MNKD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| HALO Halozyme Therapeutics, Inc. | $91.35 | $10.61B | $8.34 | - | 56 |
| NVO Novo Nordisk A/S | $37.82 | $172.11B | $3.38 | 4.90% | 59 |
| MRK Merck & Co., Inc. | $133.72 | $327.41B | $2.79 | 2.54% | 64 |
| LLY Eli Lilly and Company | $1347.11 | $1.27T | $35.48 | 0.39% | 63 |
| NKTR Nektar Therapeutics | $30.20 | $1.11B | $-8.08 | - | 39 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MNKD | $3.85 | -2.5% | 4.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |